Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

CACNA1H inhibits HR. 1 / 1

| 1

➶

reach

"When ovarian cancer cases were considered, we observed an opposite trend for all CACNA loci compared to gastric and lung adenocarcinoma (XREF_SUPPLEMENTARY) : when all disease stages were analyzed, higher expression of CACNA-1G seemed to increase the risk of death (HR 1.22, 95% CI 1.07-1.40; p = 0.004), whereas higher expression of CACNA-1H and CACNA-1I reduced the risk (HR 0.82, 95% CI 0.71-0.96; p = 0.011 and HR 0.84, 0.73-0.97; p = 0.018, respectively)."

28846697

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...